Literature DB >> 26681718

Effects of GLP-1 Receptor Agonists on Heart Rate and the Autonomic Nervous System Using Holter Electrocardiography and Power Spectrum Analysis of Heart Rate Variability.

Yuki Nakatani1, Atsuhiko Kawabe2, Mihoko Matsumura3, Yoshimasa Aso3, Takanori Yasu2, Nobuyuki Banba4, Takaaki Nakamoto2.   

Abstract

Entities:  

Year:  2015        PMID： 26681718     DOI： 10.2337/dc15-1437

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  18 in total

1.  Exenatide modulates visual cortex responses.

Authors:  Paola Binda; Roy Eldor; Claudia Huerta; John Adams; John Lancaster; Peter Fox; Stefano Del Prato; Ralph DeFronzo; Muhammad Abdul-Ghani; Giuseppe Daniele
Journal:  Diabetes Metab Res Rev       Date:  2019-05-06       Impact factor: 4.876

2.  The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.

Authors:  Yi-Hsin Chan; Tze-Fan Chao; Shao-Wei Chen; Hsin-Fu Lee; Pei-Ru Li; Wei-Min Chen; Yung-Hsin Yeh; Chi-Tai Kuo; Lai-Chu See; Gregory Y H Lip
Journal:  Cardiovasc Diabetol       Date:  2022-06-28       Impact factor: 8.949

Review 3.  Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential.

Authors:  Michael E Røder
Journal:  Ther Adv Chronic Dis       Date:  2017-11-09       Impact factor: 5.091

Review 4.  Safe and pragmatic use of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement.

Authors:  Sanjay Kalra; Sujoy Ghosh; A H Aamir; Md Tofail Ahmed; Mohammod Feroz Amin; Sarita Bajaj; Manash P Baruah; Uditha Bulugahapitiya; A K Das; Mimi Giri; Sonali Gunatilake; Saeed A Mahar; Md Faruque Pathan; Nazmul Kabir Qureshi; S Abbas Raza; Rakesh Sahay; Santosh Shakya; Dina Shreshta; Noel Somasundaram; Manilka Sumanatilleke; A G Unnikrishnan; Achini Madushani Wijesinghe
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

5.  GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose.

Authors:  Yusaku Iwasaki; Mio Sendo; Katsuya Dezaki; Tohru Hira; Takehiro Sato; Masanori Nakata; Chayon Goswami; Ryohei Aoki; Takeshi Arai; Parmila Kumari; Masaki Hayakawa; Chiaki Masuda; Takashi Okada; Hiroshi Hara; Daniel J Drucker; Yuichiro Yamada; Masaaki Tokuda; Toshihiko Yada
Journal:  Nat Commun       Date:  2018-01-09       Impact factor: 14.919

Review 6.  Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.

Authors:  Martin Lorenz; Francesca Lawson; David Owens; Denis Raccah; Christine Roy-Duval; Anne Lehmann; Riccardo Perfetti; Lawrence Blonde
Journal:  Cardiovasc Diabetol       Date:  2017-01-13       Impact factor: 9.951

Review 7.  Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review.

Authors:  Jerry Meece
Journal:  Diabetes Ther       Date:  2018-03-24       Impact factor: 2.945

8.  Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.

Authors:  Vittorio Cacciatori; Giacomo Zoppini; Federico Bellavere; Riccardo Rigolon; Karl Thomaseth; Isabella Pichiri; Maddalena Trombetta; Marco Dauriz; Francesca De Santi; Giovanni Targher; Lorenza Santi; Enzo Bonora
Journal:  J Endocr Soc       Date:  2017-11-06

Review 9.  Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors: A narrative review of head-to-head comparisons.

Authors:  Niels B Dalsgaard; Tina Vilsbøll; Filip K Knop
Journal:  Diabetes Obes Metab       Date:  2017-11-08       Impact factor: 6.577

Review 10.  Safety of Semaglutide.

Authors:  Mark M Smits; Daniël H Van Raalte
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-07       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.